We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$617B
AUM Growth
-$21.7B
Cap. Flow
-$32.7B
Cap. Flow %
-5.31%
Top 10 Hldgs %
14.52%
Holding
11,616
New
1,319
Increased
4,145
Reduced
4,502
Closed
1,184

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.87B
2
AAPL icon
Apple
AAPL
+$1.41B
3
MSFT icon
Microsoft
MSFT
+$1.16B
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.03B
5
LUV icon
Southwest Airlines
LUV
+$727M

Sector Composition

Rank Sector Weight
1 Technology 17.52%
2 Financials 9.54%
3 Healthcare 6.68%
4 Industrials 6.61%
5 Consumer Discretionary 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMDW icon
10026
Ainos Warrants
AIMDW
$80.7K
$169 ﹤0.01%
1,376
-936
-40% -$143
GNPX icon
10027
Genprex
GNPX
$2.16M
$165 ﹤0.01%
4
-143
-97% -$20.1K
RAC.WS
10028
Rithm Acquisition Corp Warrants
RAC.WS
$165 ﹤0.01%
300
SES.WS icon
10029
SES AI Corp Warrants
SES.WS
$4.82M
$161 ﹤0.01%
848
+231
+37% +$70
RULE icon
10030
Adaptive Core ETF
RULE
$15.8M
$160 ﹤0.01%
+7
New +$160
LRE
10031
Lead Real Estate
LRE
$18.1M
$157 ﹤0.01%
+100
New +$143
ALCY
10032
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$156 ﹤0.01%
11
-990
-99% -$11.8K
IPST
10033
IP Strategy Holdings
IPST
$1.52M
$156 ﹤0.01%
5
-4
-44% -$742
YSXT
10034
YSX Tech Co Ltd
YSXT
$32.8M
$156 ﹤0.01%
125
-2,573
-95% -$5.53K
NAMMW
10035
Namib Minerals Warrants
NAMMW
$3.72M
$153 ﹤0.01%
2,190
ARQQW icon
10036
Arqit Quantum Warrants
ARQQW
$133K
$151 ﹤0.01%
+982
New +$487
UCFIW
10037
CN Healthy Food Tech Group Warrant
UCFIW
$150 ﹤0.01%
+1,665
New +$150
LIMNW
10038
Liminatus Pharma Warrants
LIMNW
$147 ﹤0.01%
4,212
+3,922
+1,352% +$396
FMTL
10039
First Trust Indxx Critical Metals ETF
FMTL
$28.8M
$146 ﹤0.01%
+5
New +$134
YOUL
10040
Youlife Group Inc
YOUL
$33.7M
$143 ﹤0.01%
100
-1,039
-91% -$1.83K
MCHX icon
10041
Marchex
MCHX
$79.7M
$141 ﹤0.01%
85
+27
+47% +$46
SNAV icon
10042
Mohr Sector Nav ETF
SNAV
$30.3M
$140 ﹤0.01%
+4
New +$139
FEED
10043
ENvue Medical Inc
FEED
$3.72M
$139 ﹤0.01%
60
+25
+71% +$118
SRTAW
10044
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$138 ﹤0.01%
+1,279
New +$212
FUSE
10045
Fusemachines Inc
FUSE
$24.8M
$135 ﹤0.01%
+82
New +$170
DTI icon
10046
Drilling Tools International
DTI
$80.1M
$132 ﹤0.01%
54
-5,172
-99% -$12.4K
ATNM icon
10047
Actinium Pharmaceuticals
ATNM
$25M
$131 ﹤0.01%
96
-14,480
-99% -$21.1K
NRXPW
10048
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$131 ﹤0.01%
1,852
+1,834
+10,189% +$183
MACIW
10049
Melar Acquisition Corp I Warrant
MACIW
$131 ﹤0.01%
939
-34
-3% -$6
XLO icon
10050
Xilio Therapeutics
XLO
$60.3M
$130 ﹤0.01%
15
-960
-98% -$10.1K

Similar funds

UBS Group's Q4 2025 Portfolio in Review

As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.

  • UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
  • UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
  • UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
  • UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
  • UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
  • UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.